BOSTON, Oct. 30, 2024 /PRNewswire/ -- Volta Labs™, a genomics applications company, announced today that it has joined the PacBio Compatible program, further expanding the partnership between Volta ...
BOSTON and BOULDER, Colo., Feb. 23, 2026 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) General Meeting 2026 in Orlando, FL, Volta Labs, a leader in next-generation sequencing ...
The bioautomation company emerges from stealth mode with investment led by Maverick Ventures and John Stuelpnagel, co-founder of Illumina CAMBRIDGE, Mass.--(BUSINESS WIRE)--Volta Labs, a bioautomation ...
BOSTON, Feb. 24, 2025 /PRNewswire/ -- Volta Labs, a leading genomics applications company, today announced its four strategic focus areas for 2025 and the expansion of the Callisto App menu to include ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Volta Labs, a bioautomation company developing solutions to streamline the upstream workflows in genomic sequencing, today announced numerous advances in digital ...
Twenty years ago, getting a human genome sequenced was a billion-dollar, international project. Today, you can get your dog’s genome sequenced by the end of the month for a few bucks. It speaks to the ...
BOSTON, April 28, 2025 /PRNewswire/ -- Volta Labs, Inc. today announced the launch of the Volta Access Program, a new initiative aimed at increasing access to its Callisto™ Sample Prep System for ...
The MarketWatch News Department was not involved in the creation of this content. BOSTON and BOULDER, Colo., Feb. 23, 2026 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) ...
As whole genome sequencing continues to expand across clinical research and translational settings, PCR-free workflows are increasingly preferred to minimize amplification bias, reduce sequencing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results